A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study

Janet S. Rader, Michael W. Sill, Jan H. Beumer, Heather A. Lankes, Doris Mangiaracina Benbrook, Francisco Garcia, Connie Trimble, J. Tate Thigpen, Richard Lieberman, Rosemary E. Zuna, Charles A. Leath, Nick M. Spirtos, John Byron, Premal H. Thaker, Shashikant Lele, David Alberts

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences